BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 20706150)

  • 21. Esomeprazole versus pantoprazole for healing erosive oesophagitis.
    Vcev A; Begić I; Ostojić R; Jurcić D; Bozić D; Soldo I; Gmajnić R; Kondza G; Khaznadar E; Mićunović N
    Coll Antropol; 2006 Sep; 30(3):519-22. PubMed ID: 17058517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis.
    Fennerty MB; Johanson JF; Hwang C; Sostek M
    Aliment Pharmacol Ther; 2005 Feb; 21(4):455-63. PubMed ID: 15709997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    BMC Pediatr; 2010 Jun; 10():41. PubMed ID: 20540767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
    Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S16-23. PubMed ID: 26422093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esomeprazole 40 mg administered intravenously has similar safety and efficacy profiles to the oral formulation in patients with erosive esophagitis.
    Schneider H; Van Rensburg C; Schmidt S; Aboo N; Makela H; Nauclér E; Hallerback B; Svedberg LE
    Digestion; 2004; 70(4):250-6. PubMed ID: 15687727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
    Orlando RC; Monyak JT; Silberg DG
    Curr Med Res Opin; 2009 Sep; 25(9):2091-102. PubMed ID: 19601705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esomeprazole for the treatment of GERD in infants ages 1-11 months.
    Winter H; Gunasekaran T; Tolia V; Gottrand F; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):14-20. PubMed ID: 22241513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE; Bochenek W
    Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
    Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S16-23. PubMed ID: 26121345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus.
    Vieth M; Kulig M; Leodolter A; Nauclér E; Jaspersen D; Labenz J; Meyer-Sabellek W; Lind T; Willich S; Malfertheiner P; Stolte M
    Aliment Pharmacol Ther; 2006 Jan; 23(2):313-9. PubMed ID: 16393312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.
    Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):530-7. PubMed ID: 18030229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials.
    Gralnek IM; Dulai GS; Fennerty MB; Spiegel BM
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1452-8. PubMed ID: 17162239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.
    Glatzel D; Abdel-Qader M; Gatz G; Pfaffenberger B
    Digestion; 2006; 74(3-4):145-54. PubMed ID: 17230024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
    Malfertheiner P; Nocon M; Vieth M; Stolte M; Jaspersen D; Koelz HR; Labenz J; Leodolter A; Lind T; Richter K; Willich SN
    Aliment Pharmacol Ther; 2012 Jan; 35(1):154-64. PubMed ID: 22070159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.
    Glatzel D; Abdel-Qader M; Gatz G; Pfaffenberger B
    Digestion; 2007; 75 Suppl 1():69-78. PubMed ID: 17489035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.
    Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
    Am J Gastroenterol; 2012 Sep; 107(9):1354-60. PubMed ID: 22777339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
    Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
    Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment.
    Giannini EG; Zentilin P; Dulbecco P; Vigneri S; Scarlata P; Savarino V
    Am J Gastroenterol; 2008 Feb; 103(2):267-75. PubMed ID: 18289194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.
    Kahrilas PJ; Dent J; Lauritsen K; Malfertheiner P; Denison H; Franzén S; Hasselgren G
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1385-91. PubMed ID: 17950677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.